Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CAPR
CAPR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CAPR News
Capricor Therapeutics Q1 2026 Earnings Call Insights
May 13 2026
seekingalpha
Capricor Therapeutics to Announce Q1 Earnings on May 12
May 12 2026
seekingalpha
Capricor Executive Exercises Stock Options in $793K Transaction
May 10 2026
Fool
Krasney Sells Shares for Diversification Under 10b5-1 Plan
May 10 2026
NASDAQ.COM
Capricor Sues Nippon Shinyaku Over Pricing Flaw
May 08 2026
seekingalpha
Middle East Tensions Ease as Investors Await Jobs Data
May 08 2026
stocktwits
Capricor Sues NS Pharma Over Deramiocel Launch Issues
May 08 2026
stocktwits
FDA Leadership Contender Sparks Market Interest
May 04 2026
stocktwits
Capricor's Biologics Application Under FDA Review
Apr 22 2026
stocktwits
Capricor Presents Phase 3 Data for DMD Therapy Deramiocel
Apr 22 2026
Newsfilter
Capricor's Former Executive Considered for FDA Biologics Chief
Apr 14 2026
stocktwits
Analysts Bullish on Capricor's Treatment Prospects
Mar 13 2026
stocktwits
CAPRICOR THERAPEUTICS INC: B. RILEY INCREASES TARGET PRICE FROM $50 TO $63
Mar 13 2026
moomoo
CAPR Stock Poised for Strongest Weekly Performance in Almost a Month: CEO Asserts 'No Chance' of Deramiocel Receiving Just Conditional Approval
Mar 13 2026
stocktwits
Capricor (CAPR) Q4 2025 Earnings Call Transcript
Mar 13 2026
NASDAQ.COM
Capricor Therapeutics Q4 2025 Earnings Call Insights
Mar 13 2026
seekingalpha
Show More News
